Investment in Nippon India Credit Opportunities AIF Scheme II.

Date: November 04, 2026 The Bombay Stock Exchange (BSE Limited) Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Name: AMWILL. Company Scrip Code.: 544353 Re: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") read with SEBI Master Circular no. (Ref: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”). Subject: Investment in Nippon India Credit Opportunities AIF Scheme II. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, read with the Company’s Policy for Determination of Materiality, and further to our intimation dated August 08, 2026 regarding the approval of the investment limit by the Investment Committee, we wish to inform you that the Company has on November 04, 2026 made a commitment of ₹3,00,00,000/- (Rupees Three Crore only) in Nippon India Credit Opportunities AIF Scheme II, a SEBI-registered Alternative Investment Fund. The investment is within the limit approved on August 08, 2026 and is funded through internal accruals. The amount will be drawn down in tranches. The AIF, its sponsor and manager are not related parties of the Company. This disclosure is being made in compliance with Regulation 30 of the SEBI Listing Regulations and is submitted for your information and record, will be available on the website of the Company www.amwillhealthcare.com. Thanking You. FOR AMWILL HEALTH CARE LIMITED Anshu Anshuman Company Secretary and Compliance Officer ACS 65515 Place: Bangalore